These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 18511559)

  • 1. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
    Zhong L; Li B; Mah CS; Govindasamy L; Agbandje-McKenna M; Cooper M; Herzog RW; Zolotukhin I; Warrington KH; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7827-32. PubMed ID: 18511559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression.
    Zhong L; Li B; Jayandharan G; Mah CS; Govindasamy L; Agbandje-McKenna M; Herzog RW; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
    Virology; 2008 Nov; 381(2):194-202. PubMed ID: 18834608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis.
    Zhong L; Zhao W; Wu J; Li B; Zolotukhin S; Govindasamy L; Agbandje-McKenna M; Srivastava A
    Mol Ther; 2007 Jul; 15(7):1323-30. PubMed ID: 17440440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?
    Aslanidi GV; Rivers AE; Ortiz L; Song L; Ling C; Govindasamy L; Van Vliet K; Tan M; Agbandje-McKenna M; Srivastava A
    PLoS One; 2013; 8(3):e59142. PubMed ID: 23527116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.
    Li M; Jayandharan GR; Li B; Ling C; Ma W; Srivastava A; Zhong L
    Hum Gene Ther; 2010 Nov; 21(11):1527-43. PubMed ID: 20507237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
    Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
    Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
    Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.
    Markusic DM; Herzog RW; Aslanidi GV; Hoffman BE; Li B; Li M; Jayandharan GR; Ling C; Zolotukhin I; Ma W; Zolotukhin S; Srivastava A; Zhong L
    Mol Ther; 2010 Dec; 18(12):2048-56. PubMed ID: 20736929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
    Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
    J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo.
    Li B; Ma W; Ling C; Van Vliet K; Huang LY; Agbandje-McKenna M; Srivastava A; Aslanidi GV
    Hum Gene Ther Methods; 2015 Dec; 26(6):211-20. PubMed ID: 26421998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.
    Gabriel N; Hareendran S; Sen D; Gadkari RA; Sudha G; Selot R; Hussain M; Dhaksnamoorthy R; Samuel R; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):80-93. PubMed ID: 23379478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses.
    Ling C; Li B; Ma W; Srivastava A
    Hum Gene Ther Methods; 2016 Aug; 27(4):143-9. PubMed ID: 27431826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.
    Boye SL; Bennett A; Scalabrino ML; McCullough KT; Van Vliet K; Choudhury S; Ruan Q; Peterson J; Agbandje-McKenna M; Boye SE
    J Virol; 2016 Apr; 90(8):4215-4231. PubMed ID: 26865709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single tyrosine mutation in AAV8 vector capsid enhances gene lung delivery and does not alter lung morphofunction in mice.
    Martini SV; da Silva AL; Ferreira D; Gomes K; Ornellas FM; Lopes-Pacheco M; Zin E; Petrs-Silva H; Rocco PR; Morales MM
    Cell Physiol Biochem; 2014; 34(3):681-90. PubMed ID: 25171090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.
    Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE
    Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
    Cheng B; Ling C; Dai Y; Lu Y; Glushakova LG; Gee SW; McGoogan KE; Aslanidi GV; Park M; Stacpoole PW; Siemann D; Liu C; Srivastava A; Ling C
    Gene Ther; 2012 Apr; 19(4):375-84. PubMed ID: 21776025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.
    Petrs-Silva H; Dinculescu A; Li Q; Min SH; Chiodo V; Pang JJ; Zhong L; Zolotukhin S; Srivastava A; Lewin AS; Hauswirth WW
    Mol Ther; 2009 Mar; 17(3):463-71. PubMed ID: 19066593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration.
    Mary B; Maurya S; Kumar M; Bammidi S; Kumar V; Jayandharan GR
    Mol Pharm; 2019 Nov; 16(11):4738-4750. PubMed ID: 31596095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina.
    Petrs-Silva H; Dinculescu A; Li Q; Deng WT; Pang JJ; Min SH; Chiodo V; Neeley AW; Govindasamy L; Bennett A; Agbandje-McKenna M; Zhong L; Li B; Jayandharan GR; Srivastava A; Lewin AS; Hauswirth WW
    Mol Ther; 2011 Feb; 19(2):293-301. PubMed ID: 21045809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.